Pharmaceutical Company Strategy Blocks Generic-Drug Makers

Researchers have evaluated how current policy and physician-prescribing behavior allow pharmaceutical companies to maintain market share by the sequential launch of branded reformulations not shown to be superior to first-generation products.
Medscape Today